Clinical Trials Browser

Phase 1/2 × Ovarian Neoplasms × Everolimus × Clear all

NCT01149434 2014-10-06

Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers

Phase 1/2 Terminated

19 enrolled 11 charts

GastrointestinalGynecologic

Colonic Neoplasms, Neoplasms, Ovarian Neoplasms